HEALTHMEDPAGE TODAY
'Wait a Minute. Isn’t This the Same Drug?': What We Heard This Week
The FDA approved a depression drug despite more negative than positive studies. Dr. Erick Turner of Oregon Health & Science University questioned the approval, noting the drug's mixed study results.
Mentioned
Related Signal
Adjacent reporting
- How a Drug With More Negative Than Positive Studies Won FDA Approval
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
- STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
- White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’
- STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more